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I. Introduction 
This paper explores the use of forensics outside of the criminal context, specifically in 
regard to pulmonary emboli.
1
 This paper will analyze what pulmonary embolism are, how they 
interact with the rest of the body, what causes them, and the legal considerations that arise 
because of them. Pulmonary embolism is common and deadly, making them a subject in a vast 
amount of medical malpractice litigation. This paper aims to educate the public and attorneys as 
to how this condition can be prevented and how to prove pulmonary embolism in civil suits 
regarding claims of malpractice.  
II. The Vascular System 
The circulatory system in the human adult is comprised of an astounding 60,000 miles of 
blood vessels. The vessels serve as a continuous pipe-like conduit for the flow of blood 
throughout the body, pumped by the heart. Arteries, arterioles, and capillaries convey blood from 
the heart to the tissues and organs of the body, while venules and veins serve to transport blood 
from the body back to the heart. The heart pumps six quarts of blood per minute via the blood 
vessels (360 quarts per hour).
2
  
The heart (see Figure 1) is the key component of the vascular system. It is approximately 
the size of a human fist and is situated in the upper mid-chest articulated slightly to the left. The 
heart is a hydraulic pump that sends blood via the vascular system both to and from the tissues 
and organs of the body. The aorta, the heart's large artery, sends out oxygen and nutrient rich 
blood that travels through arteries and then arterioles that connect with the network of capillaries. 
The small capillaries conduct at the cellular level the transfer of oxygen and nutrients to enrich 
                                                        
1
 Pulmonary Embolism: blood clots which travel to the lungs.  
2
 Leahy, Monique C.M. Medical Malpractice Liability for Blood Clot, Deep Vein Thrombosis, 
Pulmonary Embolism, or Clot-Provoked Strike Causing Injury or Death, 135 Am. Jur. Trials 207 
(Aug. 2016). 
4 
the organs of the body and exchange that for waste such as carbon dioxide to be moved back 
through the system.
3
 
The superior vena cava is the large vein that carries blood from the upper body to the 
right atrium. This major vein is formed from tributaries draining the head, neck, and arms. (See 
Figure 2.) The inferior vena cava carries blood from the legs, back, and abdomen to the right 
atrium. (See Figure 3.)
4
 
The internal iliac vein drains pelvic organs, the pelvic wall, and part of the thigh, and 
joins the external iliac vein to form the common iliac vein. The common iliac veins from each 
side join to form the inferior vena cava. Later, in its course within the abdomen, the inferior vena 
cava receives the renal veins. In addition, the venous drainage from the stomach, spleen, and 
intestine is carried by the portal vein to the liver. Blood leaving the liver flows through the 
hepatic veins, which enter the inferior vena cava as it passes through the diaphragm.
5
  
Veins are wide and relatively thin-walled channels which offer little resistance to the 
flow of blood and are much more easily compressed than arteries. Like artery walls, vein walls 
are composed of three layers: the intima lining the lumen,
6
 the media, and the outer adventitia. 
The intima consists of a single layer of endothelial cells (flat cells that line the blood vessels) and 
the sub-endothelium,
7
 which contains basement membrane.
8
  
All but the largest and smallest veins contain valves. Valves consist of a number of 
semicircular folds of the intima projecting into the lumen. Valves prevent the flow of blood away 
                                                        
3
 Russ, Freeman and McQuade, Attorneys Medical Advisor §§ 5:1 to 5:14.   
4
 Mann, C. Katherine. Thrombophlebitis, 10 Am. Jur. Proof of Facts 3d 369 (Sept. 2016). 
5
 Id. 
6
 Lumen: The passageway within a vein. 
7
 Subendothelium: The lining of the blood vessels made up of flat cells.  
8
 Basement membrane: is a thin layer of delicate noncellular material of a fine filamentous 
texture underlying the endothelium. American Jurisprudence Proof of Facts 3d, Taber's 
Cyclopedic Medical Dictionary (16th ed.).   
5 
from the heart. When skeletal muscles contract, the veins are compressed and the blood within 
their lumens is forced towards the heart.
9
 
Figure 1: The Heart and Lungs
10
 
 
  
                                                        
9
 Ogston, Venous Thrombosis: Causation and Prediction 4–7 (1987)   
10
 Pulmonary Elmbolism Following Laproscopic Gastric Bypass, Illustrated Verdict, 
http://www.illustratedverdict.com/projectreview/IV/IV_V1_2012web/1650w3lg.jpg  
6 
Figure 2. Major veins of the upper body
11
 
 
Figure 3. Major veins of the lower body
12
 
 
                                                        
11
 10 Am. Jur. Proof of Facts 369 at 13. 
12
 Id at 14.  
7 
 
Blood, in turn, nourishes the cells and essential organs of the body by the intricate 
transmission of oxygen and nutrients which it carries, and pumps away "dirty blood" containing 
waste products, which are then filtered and eliminated through the liver and kidneys.
13
  
Blood consists of plasma containing semisolid red and white blood corpuscles, lymph 
corpuscles, and platelets. The red corpuscles transport oxygen and nutrients to individual cells. 
White and lymph corpuscles carry waste products away from the cells. Platelets serve as a 
coagulant.
14
 
a. Pulmonary Embolism and Venous Thrombosis 
Pulmonary embolism occurs when a blood clot clogs one of the pulmonary arteries, 
blocking blood flow to a part of the lung
15
 with often fatal results. Pulmonary embolism is 
estimated to cause 50,000 deaths per year in the United States. The larger the embolism, the 
more likely it is to be fatal. An embolism large enough to block both pulmonary arteries at once 
is called a “saddle” embolus. The usual cause of the clot is a deep vein thrombophlebitis16 in a 
leg vein or in the pelvic veins. This accounts for 70% of pulmonary embolisms.
17
 Deep vein 
thrombosis, commonly referred to as "DVT," occurs when a blood clot or thrombus, develops in 
the large veins of the legs or pelvic area. Some DVTs may cause no pain, whereas others can be 
quite painful. With prompt diagnosis and treatment, the majority of DVT's are not life 
threatening. However, a blood clot that forms in the invisible "deep veins" can be life 
                                                        
13
 DeBakey, The New Living Heart 36 (Adams Media Corp., 1997). 
14
 Coagulation: The process by which the blood forms clots; Penofsky, Daniel J. Litigating 
Vascular Medical Malpractice Cases. 10 Am. Jur. Trials 1, 38 (2007) 
15
 Diagnosing and Treating Pulmonary Embolism, 8 Medico-Legal Watch 17.  
16
 Thrombophlebitis: inflammation of the vein coupled with thrombosis 
17
 Tennenhouse, Dan J. Pulmonary Embolism, 2 Attorneys Medical Deskbook § 24:5. 
8 
threatening. A clot that forms in the large, deep veins is more likely to break free and travel 
through the vein. It is then called an embolus.
18
  
The term "thrombophlebitis" has come into general use to designate two closely 
associated conditions: clot formation in a vein and inflammation of the vein wall. 
Thrombophlebitis may be defined as a partial or complete closing of a vein by a clot with 
preceding or secondary inflammation of the wall of the vein.
19
 There are two types of emboli: 
arterial and venous. Arterial emboli usually originate in the left side of the heart in persons with 
heart disease. These emboli can travel to the brain, kidneys, spleen, or the extremities.
20
 Venous 
emboli usually originate in the veins of the lower extremities and travel through the venous 
system through the right side of the heart and into the lungs, where they can produce a 
pulmonary embolism or a pulmonary infarction,
21
 or both. A pulmonary infarction is usually 
fatal.
22
  
Traumatic thrombophlebitis of the superficial veins is more likely to develop as a result 
of direct trauma than is thrombophlebitis of the deep veins. In the deep veins the condition most 
often develops as a secondary reaction to trauma elsewhere. Thrombophlebitis in the deep veins 
is particularly treacherous because it is likely to develop without visible inflammation of the vein 
walls. A clot may break loose without warning and lodge in the lung region. Venous 
thromboembolic disease is a major source of morbidity and mortality, especially among 
                                                        
18
 Deep Vein Thrombosis, Vascular Disease Foundation, 2012.  
19
 10 Am. Jur. Proof of Facts 369 at 12. 
20
 Id. 
21
 Pulmonary Infarction: A condition in which one or more arteries in the lungs become blocked 
by a blood clot. 
22
 Shafer, Traumatic Thrombophlebitis, 10 Lawyer's Medical Journal 2d 648, 651 (1982).   
9 
hospitalized persons. Because of the lack of uniform diagnostic methods, the incidence of deep 
vein thrombosis is difficult to estimate.
23
 
In the case of thrombosis of the deep veins, a distinction is sometimes drawn between 
thrombophlebitis and phlebothrombosis. The former is used to describe a thrombus which is 
adherent to an inflamed vein wall; the latter is used to describe a fresh thrombus free from, or 
just loosely adherent to, a normal, non-inflamed vein wall. It is recognized, however, that the 
presence of a thrombus in the lumen of a vein elicits an inflammatory reaction. 
Phlebothrombosis may be regarded, therefore, as an earlier phase of thrombophlebitis. The terms 
thrombophlebitis and venous thrombosis are used, generally, to cover both superficial 
thrombophlebitis and deep vein thrombosis.
24
  
b. Clot Forming Process 
The body maintains the integrity of its circulatory system following an injury through the 
process of hemostasis.
25
 This process allows blood to continue circulating while permitting the 
blood to clot in necessary areas, such as the site of a cut. Blood loss prevention is vital and 
occurs when several elements work together to form a blood clot, which acts as a barrier to 
further blood loss. The basic components involved in the clotting process are the blood vessel 
(which constricts when injured), the platelet, and coagulation or clotting factors that circulate in 
the bloodstream. When there is a cut or damage, the blood vessel wall constricts, minimizing 
blood loss even before clotting begins.
26
 Although the initiating factors may be quite variable, 
                                                        
23
 Id.  
24
 Ogston, Venous Thrombosis: Causation and Prediction 3 (1987).   
25
 Hemostasis: The arrest of bleeding or circulation. 
26
 135 Am. Jur. Trials at 9. 
10 
the clot-forming process, once established, is generally similar in all cases no matter what the 
cause.
27
 
Platelets play an important role in blood clot formation. When a vessel wall is injured, 
platelets adhere to each other and to the edges of the injury site and form a plug that covers the 
area. The adhesion of platelets to the vessel wall and the aggregation of platelets to each other is 
followed by the deposition of fibrin,
28
 which serves to stabilize the plug. The fibrin, formed by 
the coagulation system, is deposited as fine interlacing filaments in which red and white blood 
cells and platelets are entangled.
29
 When enough platelets collect at the damaged site, a plug or 
white thrombus forms. If the damaged area is very small, the platelet plug may be enough to stop 
the bleeding. If not, the blood clotting mechanisms are triggered.
30
 
c. Initiation of Thrombosis 
Three initiating factors have been recognized in the formation of thrombi in the veins: 
changes in the vessel wall, changes in blood flow, and changes in blood coagulability. These 
factors are known as Virchow's triad.
31
  
i. Changes in the Vessel Wall 
The intact lining of the vessel prevents the formation of a thrombus on the vessel wall 
under normal circumstances. Platelets do not adhere to normal lining, but injury resulting in 
exposure of sub-lining structures is followed by the accumulation of platelets and the buildup of 
                                                        
27
 10 Am. Jur. Proof of Facts 369 at 16 
28
 Fibrin: A whitish, threadlike protein formed by the action of the enzyme thrombin on the 
protein fibrinogen. This process is the basis of blood clotting. 
29
 Id.  
30
 Russ, Freeman and McQuade, Attorneys Medical Advisor §§ 6:9, 6:10; Thrombophlebitis 
(Venous Thrombosis), 10 Am. Jur. Proof of Facts 3d 369.   
31
 10 Am. Jur. Proof of Facts 3d 369 at 17.  
11 
a platelet mass extending into the vessel lumen.
32
 The importance of damage to the vein in the 
development of venous thrombosis is controversial. It is probable that the majority of venous 
thrombi in the legs are not the result of local trauma; exceptions are cases of femoral vein 
thrombi associated with hip replacement surgery and cases of femoral neck fractures.
33
  
ii. Changes in Blood Flow 
While stasis by itself is not likely to result in thrombosis, such reduction in blood flow 
clearly has an important influence on the development of thrombosis. This importance probably 
lies in the role of stasis in reducing the washing away of loose masses of platelets at the margins 
of the developing thrombosis, and in slowing the rate at which activated coagulation factors are 
removed, thereby facilitating local accumulation. Additionally, slowing of the blood flow leads 
to an increase in viscosity, which itself leads to a further reduction in flow.
34
  
While there is doubt about whether stasis alone can induce venous thrombosis, there is 
abundant evidence that stasis is frequently associated with deep vein thrombosis of the lower 
limb and is likely to be an important contributory factor in the production of thrombosis in a 
number of situations, such as during and after surgery. Such evidence includes a report that a 
decrease in velocity of venous blood flow in the leg occurs in the majority of persons during 
surgical operations.
35
 
iii. Blood Coagulability 
                                                        
32
 Erskine, "Blood Vessels and Lymphatics," in Krupp, Chatton & Tierney, eds, Current Medical 
Diagnosis and Treatment  (1986).   
33
 Ogston, Venous Thrombosis: Causation and Prediction 54 (1987)  
34
 Malone & Morris, The Sequestration and Margination of Platelets and Leucocytes in Veins 
During Conditions of Hypokinetic and Anaemic Hypoxia, 12 Journal of Pathology 119 (1978); 
Morrison et al., The Effects of Anoxia on the Morphology and Composite Metabolism of the 
Intact Aortic Intima-Media Preparation, 59 Journal of Clinical Investigation 1027 (1977).   
35
 Doran, Drury & Sivyer, A Simple Way to Combat the Venous Stasis Which Occurs in the 
Lower Limb During Surgical Operations, 51 British Journal of Surgery 486 (1964).   
12 
The role of altered blood coagulability in the production of venous thrombosis has been 
widely debated.
36
 Altered blood coagulability can take the form of an increased level of 
coagulation factors, the presence of activated clotting factors, or altered fibrinolytic capacity to 
remove forming fibrin. There can be little argument that these factors contribute to the growth 
and ultimate size of a thrombus, but few authorities would claim that the factors are responsible 
for the initiation of venous thrombosis. Likewise, venous stasis alone is not likely to be a 
sufficient stimulus for thrombus formation. However, the combination of stasis and the presence 
of activated coagulation factors has been shown repeatedly under experimental conditions to be 
sufficient for the production of venous thrombosis. It has been proposed that the activated 
clotting factors may be formed locally or generated at a distant site, but the precise mode of 
initial activation is the subject of speculation. What is clear is that once thrombin is formed, 
platelets are activated. In the absence of effective neutralization of the thrombin, a feedback 
mechanism leads to the further generation of thrombin. The result is the buildup of a fibrin-
platelet mass.
37
  
III. Predisposition and Preexisting Conditions 
Physicians have long understood some of the precipitating causes of deep venous 
thrombosis: injury to the vessel wall, venous stasis, and changes in coagulation. Thus, physicians 
know that a whole host of conditions can contribute to the formation of deep venous thrombosis: 
injury to vessel walls of the lower extremities caused by trauma, such as fractures or burns; 
venous stasis due to obesity, congestive heart failure, peripheral vascular disease, pregnancy, 
prolonged bed rest, or traveling; and increased coagulability of the blood, brought on by 
malignancy, surgery, aging, use of birth control pills, pregnancy, and abnormalities in the 
                                                        
36 Ogston, Venous Thrombosis: Causation and Prediction 56 (1987). 
37
 Id.    
13 
blood.
38
 Obviously, if there is a combination of factors, the risk increases. For example, 
pregnancy is accompanied not only by venous stasis due to the pressure of the enlarged uterus on 
the inferior vena cava, but also by subtle changes in the coagulation system that lead to increased 
coagulability of the blood. This combination results in a greater risk of thrombosis than the risk 
presented by stasis or increased coagulability alone.
39
  
Trauma, illness, pregnancy, and childbirth can be complicated by thrombosis, especially 
if the affected person is of advanced age; has had a previous episode of deep vein thrombosis; 
has heart disease or malignant disease; has varicose veins; is obese; uses birth control pills; or 
has abnormalities in the blood, such as polycythaemia,
40
 thrombocytosis,
41
 paroxysmal nocturnal 
hemoglobinuria,
42
 sickle cell disease,
43
 abnormal coagulation factors, a raised plasma fibrinogen, 
or defective fibrinolysis. In many persons these risk factors play a very small part; the ultimate 
trigger of the coagulation chain reaction is the hypercoagulability induced by surgery or injury, 
coupled with the reduced venous blood flow that occurs because the ill or injured patient cannot 
exercise. Nevertheless, all the conditions that predispose to thrombosis must be considered as 
risk factors of the condition.
44
  
The risk of thromboembolism following a fracture of a lower limb has long been 
recognized. Thrombosis following fracture of the upper end of the femur has received particular 
attention. Pulmonary embolism is a frequent cause of death following fracture of the hip. The 
                                                        
38
 Shafer, Traumatic Thrombophlebitis, 10 Lawyer's Medical Journal 2d 648, 649 (1982).  
39
 Id. 
40
 Polycythaemia: Excess of red blood cells.  
41
 Thrombocytosis: Increase in number of blood platelets. 
42
 Paroxysmal Nocturnal Hemoglobinuria: Breakdown of red blood cells.  
43
 Sickle Cell Disease: Abnormal red blood cells.  
44
 Browse, Burnand & Thomas, Diseases of the Veins: Pathology, Diagnosis and Treatment 301 
(1988).  
14 
incidence of thromboembolism after fractures of the lower portions of the leg is also 
substantial.
45
   
A number of autopsies have shown that the incidence of venous thromboembolic disease 
is markedly increased in persons with cardiac disease and, in particular, those with congestive 
cardiac failure. A variety of factors probably contribute to such an increase. For example, venous 
stagnation and decreased cardiac output is present in many victims of heart disease, and bedrest 
with consequent immobility is frequently a component in creating venous stasis. Changes in 
blood viscosity and hemostatic components have been reported in persons with cardiac disease; 
such changes may also contribute to the production or persistence of venous thrombi.
46
  
Malignant disease and venous thromboembolic disease are linked in a number of ways. 
Thrombosis is likely to develop when a vein is surrounded or infiltrated by a tumor, and is 
common in the terminal, wasting stages of malignant disease. Of long-standing interest has been 
the relationship between thrombophlebitis migraines (recurring attacks in various sites) and 
visceral carcinoma (cancer of the abdominal organs). Thrombophlebitis migraines may antedate 
the clinical appearance of cancer by months or years and may be regarded as an indicator of the 
possible presence of hidden malignant disease.
47
 The cause of the increased risk of 
thromboembolism in persons with malignant disease is not fully explained. Clearly, a number of 
other predisposing factors frequently coexist with malignant disease such as, advancing years, 
prolonged bedrest, and surgery.
48
  
a. Immobilization 
                                                        
45
 Fitts et al., An Analysis of 950 Fatal Injuries, 56 Surgery 663 (1964); Hjelmstedt & Bergval, 
Incidence of Thrombosis in Patients with Tibial Fractures: A Phlebographic Study, 134 Acta 
Chirurgica Scandinavica 209 (1968).  
46
 Ogston, Venous Thrombosis: Causation and Prediction 93 (1987).  
47
 Id. at 94. 
48
 Id. at 96. 
15 
Elderly patients and others with preexisting heart or lung problems are at especially high 
risk of pulmonary embolism while immobilized. The possible end result has been described as 
follows: "The suddenness of death may be extremely dramatic. A patient may stand up after a 
period of confinement to bed and suddenly topple over silently with a massive embolus."
49
  
Venous thrombosis and pulmonary emboli constitute a hazard to any patient who is 
immobilized, even if only one leg is placed at rest. The elderly are at particularly increased risk 
because they are more likely to have varicose veins and other venous abnormalities that interfere 
with the return of blood from the legs and thereby promote the development of thrombi. The 
elderly are also, of course, more likely to have preexisting heart conditions that reduce the heart's 
ability to pump against increased resistance.
50
  
Deep vein thrombi may or may not cause noticeable symptoms, such as pain and muscle 
tightness. The presence of leg thrombi can be demonstrated on X-rays after contrast material has 
been injected into the veins, but they frequently go undetected until pulmonary embolism occurs. 
For this reason, efforts are made to prevent leg thrombosis in high risk patients. For example, 
venous blood flow is increased by elevating the legs during surgery and exercising them soon 
after surgery.
51
 Anticoagulants are also administered. Alternative surgical procedures include 
tying off, clipping, folding, or otherwise interrupting the lowest portion of the inferior vena cava, 
or implantation of an "umbrella" to intercept emboli. These preventive procedures are reserved 
                                                        
49
 S. Robbins & R. Cotran, Pathologic Basis of Disease 129 (2d ed 1979) 
50
 Hair, Robert E. et. al., Complications Due to Immobilization, 39 Am. Jur. Proof of Facts 2d 
545, 18 (1984). 
51
 J. Ludbrook & G. Jamieson, "Disorders of Systemic Veins," in Davis-Christopher Testbook of 
Surgery 1829–1830 (11th ed Sabiston 1977) 
16 
for high-risk patients with whom anticoagulants cannot be employed or have proven 
ineffective.
52
  
b. Prevention of Complications 
The three most important measures in preventing physical disuse phenomena are: (1) 
active exercise, when possible; (2) passive mobilization (having medical personnel or others 
move the patient's joints through their full range of motion whenever active motion is 
impossible); and (3) frequent change of position (including the standing position for patients able 
to stand or use a tilt table or standing board).
53
  
Unfortunately, these simple measures are commonly ignored. Also, with a severely 
injured person, these measures are frequently impossible until considerable recuperation has 
occurred. A healthy person does not remain in one position, even for 30 minutes at a time, 
whether awake or asleep. The trauma victim immobilized in a bed or chair or by a cast, corset, or 
brace, particularly when in pain or under the influence of anesthetics or certain medications, is 
likely to spend long periods of time with little or no motion.
54
 Pulmonary embolism and blood 
clots in the legs are typically a complication of immobilization that can be prevented through 
proper prophylactic measures.
55
  
c. Cardiovascular Effects 
Immobilization produces significant progressive cardiovascular changes.
56
 These changes 
stem in large part from impairment of the autonomic control of the heart and the peripheral 
                                                        
52
 Merck Manual 649–651.  
53
 39 Am. Jur. Proof of Facts 545 at 9.  
54
 Id. 
55
 Robbins, Pathological Basis of Disease  
56
 Kottke, 196 JAMA 825, 829.  
17 
circulation. Signs of complications arising out of immobilization include an increase in pulse rate 
and fall in blood pressure.
57
  
The rapid fall of blood pressure when the patient is placed in an upright position, is 
caused by dilation of the blood vessels in the abdomen and the lower extremities under the 
weight of the blood volume accumulating in the lower portions of the body when the patient is 
upright. While the blood vessels normally have enough strength to contract reflexively under this 
pressure and reduce the volume, they lose this strength during prolonged disuse.
58
 
IV. Vascular Medical and Surgical Considerations 
Vascular surgery is that specialized branch of medicine which is concerned with the 
diagnosis and surgical treatment of diseases and disorders of the vascular system, exclusive of 
the intracranial (head and brain) vessels, and the arteries and veins of the heart. Vascular surgical 
treatment encompasses: (1) vascular diagnoses; (2) the performance of vascular surgical 
procedures, generally in a vascular surgeon's treatment room, under local or regional anesthesia; 
and (3) the performance of vascular surgery, generally in-hospital, under general anesthesia.
59
  
Vascular surgery, performed by a vascular surgeon following the diagnosis of a vascular 
disease or disorder, can alleviate and cure many of the diseases and disorders. In fact, each year, 
more than 200,000 vascular procedures and surgeries are performed in the U.S.
60
 For the most 
part, vascular diagnoses are accurate and vascular surgeries are generally performed without 
incident or complication, with the patient regaining normal vascular function following a 
reasonably short recuperative period. Most such successful surgeries allow the patient to regain 
                                                        
57
 Taylor et al., Effects of Bedrest on Cardiovascular Function and Work Performance, 2 (No. 5) 
Journal of Applied Physiology 223 (Nov 1949).  
58
 Id. at 237. 
59
 Penofsky, Daniel J., Litigating Vascular Surgery Malpractice Cases, 106 Am. Jur. Trials 1, 37 
(2007).  
60
 Id. at 38.  
18 
strength, mobility, physical endurance, and they promote a healthful and normal lifespan. 
However, there have been glaring examples of vascular misdiagnosis attributable to malpractice 
on the part of the diagnosing vascular surgeon, for which liability has been imposed.
61
  
Vascular surgery malpractice cases are complex. They mandate a consummate 
knowledge of the vascular system; the nature and cause of the particular vascular disease or 
disorder which has afflicted the artery or vein in question; the accuracy of the vascular surgeon's 
diagnosis; the type of vascular surgery that was performed by the vascular surgeon to treat the 
diseased or disordered artery or vein; whether the complication and physical injury were 
proximately caused by a malpractice act or omission on the part of the vascular surgeon in 
diagnosis or the performance of the vascular surgery; and whether the vascular surgeon has 
breached the applicable standard of vascular medical and surgical care in diagnosis or surgical 
treatment.
62
  
a. Types of Vascular Diseases and Disorders63 
Varicose Veins: the most frequently diagnosed venous disease or disorder affecting the 
legs. Varicose veins are superficial veins that have become swollen, distorted and ineffective. 
They may occur anywhere in the body, but the veins most commonly involved are the saphenous 
veins of the legs. Varicose veins in the leg present as thready linear or bumpy protrusions just 
beneath the skin.  
Chronic Venous Insufficiency: an obstruction or incompetence of a vein in the deep 
venous system of the leg, because of a thrombosis or blood clot(s) within the vein. The 
thrombosis blocks the venous flow of blood from the leg to the heart. This condition is 
                                                        
61
 Id.  
62
 Id.  
63
 See Davies, Venous Disease 33 (TFM Pub., 2006).  
19 
characterized by progressive edema, a reddish-brown hyper-pigmented appearance in the lower 
leg just above the ankle, recurrent skin ulceration, and poor wound healing. 
Thrombosis: a blood clot condition within a vein, which blocks the venous flow of blood 
within the afflicted vein to the heart. Thrombosis may affect peripheral and deep veins, and if an 
embolus breaks off, it can be carried to a distant part of the circulatory system, where it may 
lodge in another blood vessel.  
Phlebitis: an inflammation of a vein. When coupled with thrombosis, the condition is 
called thrombophlebitis. The thrombosis and inflammation may clinically present as superficial, 
deep, or both, creating the risk of pulmonary embolism. 
Venous Ulcer: an anatomical break and overgrowth of fibrous tissue on the skin and 
subcutaneous layer, often on the leg, ankle or foot, provoked by venous reflux. The condition is 
frequently chronic. 
Venous Valvular Incompetence: a disorder of a vein which incapacitates the valves of the 
vein and permits venous reflux, or the backflow of venous blood.  
b. Vascular Evaluation 
The vascular evaluation or examination conducted by a vascular surgeon proceeds upon 
the medical premise that many vascular diseases or disorders, especially those which affect the 
legs, are provoked by an underlying systemic disease, such as diabetes. Accordingly, not only 
must the presenting vascular disease or disorder be diagnosed and treated, but also any 
underlying provoking systemic disease as well.
64
  
The primary goal of the vascular evaluation is to make a tentative diagnosis of any 
vascular disease or disorder afflicting the patient as well as any underlying systemic disease, 
                                                        
64
 Davies, Vascular Surgery 9 (Springer-Verlag, 2006).  
20 
confirmed by diagnostic testing and imaging studies, and then to proceed upon a course of 
nonsurgical or surgical treatment to alleviate or cure the presenting vascular disease or disorder. 
Where any underlying systemic disease is treatable by the vascular surgeon, this is accomplished 
as well. Where any underlying systemic disease is non-treatable by the vascular surgeon but it is 
diagnosed, referral of the patient to an appropriate medical specialist such as a cardiologist is 
made.
65
 
c. Presenting Signs and Symptoms 
The clinical diagnosis of deep vein thrombosis can be extremely difficult because many 
persons have no signs or symptoms in the affected limb. When present, the signs and symptoms 
that are commonly produced by deep vein thrombosis are pain, swelling, and a faint blue-red 
discoloration of the skin. Deep vein thrombosis may also present as a fever of unknown origin or 
with the features of pulmonary embolism without any evidence of the disease in the legs. The 
clinical features of pulmonary embolism are chest pain, coughing up of blood, and shortness of 
breath.
66
  
The most common but most misleading indication of deep vein thrombosis is tenderness 
on compression of the calf muscles, or tenderness over the course of the main veins of the thigh. 
However, only half of those persons with calf muscle tenderness have a thrombosis.
67
 Deep vein 
thrombosis often causes mild pitting edema of the ankle. This is a significant clinical sign and is 
a true indicator of thrombosis in seventy percent of cases, especially if the edema is unilateral.
68
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The calf muscles may feel "woody" hard if there is extensive intramuscular thrombosis. If there 
is significant venous outflow obstruction, the skin of the leg may feel warm, and the superficial 
veins may be distended and fail to collapse when the limb is elevated. Distended veins in the 
affected groin of a leg with a thrombosis indicate a major degree of venous obstruction.
69
 
Systemic signs such as restlessness, fever, tachycardia,
70
 and changes in blood pressure 
may be the only signs of a deep thrombophlebitis. A pulse rate over ninety has been observed in 
seventy-five percent of the cases and fever has been observed in eighty percent of the cases.
71
 
Thus, when these signs occur following surgery or childbirth, and in the absence of any other 
localized condition, thrombophlebitis should be seriously suspected.
72
 
d. Diagnosis 
The imprecision of the clinical diagnosis of deep vein thrombosis is now generally 
accepted. In some patients, a thrombosis of a deep vein of the lower limb produces no symptoms 
or signs that might give forewarning of possible pulmonary embolism, while a considerable 
proportion of persons with clinical features suggestive of deep vein thrombosis are ultimately 
found not to have thrombotic disease. Accurate diagnostic techniques are essential for the proper 
institution of preventative measures and therapeutic regimes, and so that the application of such 
measures and regimes can be limited to those persons who require them.
73
  
There are certain conditions that can mimic active thrombosis, thus a diagnosis is 
generally referred to as a differential diagnosis. A differential diagnosis is made by comparing 
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and contrasting available information of disease signs, symptoms, physical findings, examination 
results, laboratory data, and radiologic and other imaging studies, that are possibly responsible 
for the patient's illness, then narrowing down the determination of disease or illness afflicting the 
patient to two or three possible vascular diagnoses, and then excluding all possible diagnoses 
except for the one thought most likely to be the cause of the patient's symptomatology. 
74
  
In descending order of prevalence, the conditions to be distinguished from thrombosis 
include congestive heart failure, trauma, cancer, cellulitis (spreading inflammation of tissue), 
lymphangitis (inflammation of lymphatic channels), arthritis, and paresis (partial paralysis).
75
 In 
addition, thrombophlebitis may mimic the symptoms of acute arterial ischemia (deficiency of 
blood supply), or systemic diseases such as edema from the nephrotic syndrome (kidney 
disease), and myositis ossificans (inflammation and conversion of muscle tissue to bone).
76
 
Thrombophlebitis must be distinguished from a large number of clinical conditions in 
which symptoms and signs are located in the vicinity of the calf muscles. Among these 
conditions are ruptured popliteal (Baker) cyst, muscle strain due to hematoma formation 
(hemorrhage into the limb), tennis leg, and muscle hernia (rupture). Other conditions to be 
considered are superficial thrombophlebitis located under the skin in the vicinity of the calf 
muscles, dermatitis and chronic or acute cellulitis in the same site, lymphedema with cellulitis, 
and rupture of the plantaris tendon in the calf or Achilles tendonitis (inflammation of the 
tendon).
77
 
e. Treatment 
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As a general rule of vascular medical practice, conservative nonsurgical treatment of a 
diagnosed vascular disease or disorder is initiated first, if at all possible, before surgical 
treatment is contemplated. A variety of nonsurgical vascular treatment modalities exist, 
depending upon the diagnosed vascular disease or disorder.
78
  
In cases of thrombosis in the deep veins of the leg, or phlebitis or thrombophlebitis, 
conservative nonsurgical treatment includes bed rest, elevation of the afflicted leg, and 
anticoagulation with the drug heparin. Some patients may require thrombolytic therapy, which 
involves the intravenous injection of a substance such as urokinase, streptokinase, or tissue 
plasminogen activator to dissolve the thrombus.
79
 Specific mechanical methods of 
thromboprophylaxis, which include graduated compression stockings (GCS), intermittent 
pneumatic compression (IPC) devices, and the venous foot pump (VFP), increase venous 
outflow and/or reduce stasis within the leg veins. As a group, mechanical thromboprophylaxis 
modalities have important advantages and limitations. The primary attraction of mechanical 
thromboprophylaxis is the lack of bleeding potential. These modalities, therefore, have 
advantages for patients with high bleeding risks. While all three of the mechanical methods of 
thromboprophylaxis have been shown to reduce the risk of DVT in a number of patient groups, 
they have been studied much less intensively than anticoagulant-based approaches and they are 
generally less efficacious than anticoagulant thromboprophylaxis, such as above-mentioned 
heparin.
80
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Where conservative nonsurgical treatment over time fails to alleviate or cure a diagnosed 
vascular disease or disorder, surgical intervention in the form of the performance of a vascular 
procedure or vascular surgery is considered. In the case of thrombosis in the deep veins of the 
leg, or phlebitis or thrombophlebitis, venous thrombectomy - direct surgical removal of the 
venous thrombosis - may be required.
81
 
Thrombosis in a deep vein occludes its lumen and destroys its valves; therefore, 
restoration of complete normality to the affected vein requires the removal of the thrombus 
before it has destroyed the valves. If a thrombus cannot be removed, its ultimate effect is, at 
present, beyond medical control. All that can be done is to prevent further thrombosis by giving 
anticoagulants, or to stop complications, such as pulmonary embolism, by performing surgical 
venous blockade
82
.
83
 
There are two methods for removing thrombi: thrombectomy, which is the removal of the 
thrombus by surgical means, and pharmacological thrombolysis, which is the breaking up of the 
thrombus through drug therapy. Both methods are most effective when the thrombus is fresh and 
non-adherent to the vein wall, a stage at which a thrombus is often symptomless. By the time 
symptoms appear, the thrombus has often become adherent and old, two features which make its 
removal or dissolution difficult. Whenever possible, pharmacological lysis (dissolution or 
decomposition) of thrombi is preferred to surgical thrombectomy because lysis will affect all the 
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thrombi in a limb, some of which are inaccessible to the surgeon. Clearly, pharmacological lysis 
also avoids the risks and complications of surgery.
84
  
The decision to perform a thrombectomy is based upon the nature and extent of the 
thrombus seen through diagnostic tests, specifically a venography, and the severity of the clinical 
symptoms and signs. If a fresh non-adherent thrombus is completely removed and the person is 
given anticoagulants, fatal embolism is eliminated and minor embolism rarely occurs. However, 
in cases in which the operation fails or is only partially successful, recurrent embolism is 
common - more common than in cases in which the patient was given anticoagulants alone. 
Therefore, except when it is thought to be the only way to save the limb, thrombectomy is 
advised only when the venography indicates that all of the thrombus can be removed. If the 
thrombus cannot be completely removed, a venous blockade procedure may be coupled with the 
thrombectomy.
85
 
Effective anticoagulation prevents the propagation of existing thrombi by stopping the 
formation of new thrombi, but such treatment has no effect on the behavior of existing thrombi. 
Thrombus fragmentation, retraction, or adhesion will still occur, and therefore anticoagulants do 
not prevent embolism or deep vein damage. Heparin is usually given as the initial treatment and 
can be replaced by an oral anticoagulant when the circumstances causing the hypercoagulable 
state begin to recede.
86
 
Heparin therapy does not prevent recurrent embolism.
87
 And there is no clinical evidence 
that heparin causes or accelerates thrombolysis.
88
 Nor do studies give any indication that 
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anticoagulants reduce the incidence of the post-phlebitic syndrome. All that can be expected 
from anticoagulants is the prevention of further thrombosis. Thus, anticoagulants will save a life 
or prevent later symptoms in a limb on only a few occasions.
89
  
f. Prognosis 
Of patients who are diagnosed with PE and start treatment, ~5% die of the initial PE or 
another PE within the next 7 days. However, although the risk of dying of PE differs markedly 
among patients, no validated risk prediction tool is available. Risk of dying of PE is estimated to 
be ~70% if cardiopulmonary arrest occurs (~1% of patients at presentation), 30% if there is 
shock requiring inotropic support (~5% of patients), and ~2% in patients who are not 
hypotensive. In the presence of normal systemic arterial pressure, prognosis can also differ, 
depending on (1) clinical evaluation; (2) cardiac biomarkers such as troponin or brain natriuretic 
peptide; and (3) assessment of right ventricular size and function.
90
  
V. Legal Considerations 
Generally, medical malpractice is considered to be the negligent or unskillful 
performance by a physician of the duties that are devolved and incumbent on the physician on 
account of his or her relations with the patient or of a want of proper care and skill in the 
performance of a professional act.
91
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In vascular surgery diagnosis and treatment, the patient may reasonably expect that the 
vascular surgeon will diagnose and surgically treat the patient in accordance with the applicable 
standard of vascular medical and surgical care.
92
 The patient may also reasonably expect that the 
vascular surgeon will bring to bear his or her full learning, skill, care, and experience in 
diagnosing and surgically treating the patient's diagnosed vascular disease or disorder.
93
  
Accordingly, a bad result of a vascular diagnosis, procedure or surgery, standing alone, 
will not result in the imposition of malpractice liability on the part of the vascular surgeon 
performing the diagnosis, procedure or surgery. However, where a bad result of a vascular 
diagnosis, procedure or surgery occurs as a proximate result of a provable malpractice act of 
omission or commission on the part of the vascular surgeon performing the diagnosis, procedure 
or surgery, then malpractice liability may be imposed on the vascular surgeon in the particular 
case.
94
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a. Standard of Care 
The negligence duty or standard of care or conduct may be prescribed by statute, 
regulation, ordinance or another written standard which then replaces or supersedes the general 
negligence, "reasonable person" standard of care; the violation of such a statute constitutes a 
deviation from the standard of care and supplies the breach of duty element of a negligence cause 
of action.
95
  
In the case of a duty not being prescribed by statute, it is the generally accepted rule that 
physicians who hold themselves out to be specialists in a particular field of medicine are bound 
to bring to the discharge of their professional duties as a specialist that degree of skill, care, and 
learning ordinarily possessed by specialists of a similar class, having regard to the existing state 
of knowledge in medicine. This is known as the medical specialist standard of care. The question 
of whether a physician is a medical specialist is one of fact, and is primarily for that physician's 
own determination; if the physician holds himself or herself out as such, the physician must bring 
to his or her patients that degree of skill which a specialist in the particular medical field assumes 
to possess.
96
  
Accordingly, a vascular surgeon who holds him or herself out as a specialist in the 
practice of vascular surgery is held accountable as a specialist in vascular surgery for his or her 
professional acts, including vascular diagnosis and the performance of nonsurgical and surgical 
treatment, according to what any reasonable and prudent vascular surgeon from anywhere in the 
U.S. would do in the same situation. It is not sufficient that the vascular surgeon, in the rendition 
of a vascular diagnosis or the performance of nonsurgical or surgical treatment, acted to the 
limits of his or her potential, acted in good faith, or did what was considered "usual" or 
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"customary." The test or standard of vascular medical and surgical care is what another 
responsible vascular surgeon exercising due care and skill in vascular diagnosis or vascular 
surgical treatment would have done under the identical factual circumstances. This is a higher 
standard of care than that which is imposed upon the general medical practitioner.
97
 
By now the locality rule has been virtually abrogated in most jurisdictions by general 
acceptance of the proposition that the prevailing standard of care applicable to medical 
specialists should be based upon a realistic assessment of proficiency rather than geographic 
proximity. Accordingly, application of a national rather than a local standard of care to gauge the 
skill and competency of a vascular surgeon seems entirely appropriate. This is buttressed by the 
rapid dissemination nationwide of vascular diagnostic and surgical procedure methodologies in 
peer-reviewed medical journal articles, and standardization across the U.S. in the methodology 
of vascular diagnosis and treatment.
98
  
Patients undergoing major orthopedic surgery, represent a group that has a particularly 
high risk for VTE, and routine thromboprophylaxis has been standard of care for more than 20 
years. Randomized clinical trials have demonstrated that the rates of venographic DVT and 
proximal DVT 7 to 14 days following major orthopedic surgery in patients who received no 
thromboprophylaxis are approximately 40 to 60% and 10 to 30%, respectively. With the routine 
use of thromboprophylaxis in these patients, fatal PE is now uncommon, although symptomatic 
VTE continues to be reported in 1.3 to 10% of patients within 3 months after surgery.
99
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Accordingly, every trauma unit should develop a management guideline fin the 
prevention of VTE, and every trauma patient should he assessed for his or her VTE risk and 
should be prescribed optimal thromboprophylaxis consistent with thromboembolic and bleeding 
risks. The use of LMWH,
100
 started once primary hemostasis has been achieved, is the most 
efficacious and simplest option for the majority of moderate-risk and high-risk trauma 
patients.
101
  
For example, the evidence in a malpractice action supported the circuit court's finding 
that the estate of a patient, who died of a pulmonary embolism shortly after a hysterectomy, 
failed to establish a nationally recognized standard of care as to the use of sequential 
compression devices. The court noted that the burden was on the estate of the patient to establish 
a nationally recognized standard of care as to the use of sequential compression devices and the 
breach of that standard in the malpractice action. In this case, even though the estate's expert felt 
that the doctor did not follow the standard of care for patients who were at low risk of developing 
deep vein thrombosis or pulmonary embolism, the expert offered no peer-review literature to 
support his position and he offered no literature or studies to support that his position was the 
nationally recognized standard of care.
102
  
Further, the evidence was sufficient to show that a treating physician's failure to diagnose 
a pulmonary embolism and the patient's continued treatment for pneumonia based on the 
information available to him did not fall below the standard of care, as required to support the 
medical malpractice action after the patient died from the pulmonary embolism. The physician 
was informed by a radiologist that the lung scan showed a low probability for embolism, the 
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patient's symptoms improved with the treatment for pneumonia, the patient's white blood cell 
count was consistent with pneumonia, and an invasive pulmonary angiogram to investigate a 
possible embolism would have been inappropriate due to the risks associated with the procedure, 
in view of the patient's recent surgery, age, and lack of physical activity.
103
  
While the identification of the applicable standard of care in a medical malpractice action 
is a question of law, the ultimate determination of whether a party deviated from the standard of 
care, and was therefore negligent, is a question of fact. To resolve the issue, a finder of fact must 
determine what conduct the standard of care would require under the particular circumstances 
presented by the evidence and whether the conduct of the alleged tortfeasor conformed with that 
standard.
104
 
Generally, expert testimony on the standard of care is required. To qualify as an expert 
witness in a medical malpractice action, a witness who does not practice the same specialty as 
the defendant must demonstrate that the witness is familiar with the standard of care applicable 
to the defendant's school or specialty and that his or her familiarity is sufficient to enable the 
witness to give an expert opinion as to the conformity of the defendant's conduct to those 
particular standards and not to the standards of the witness's school and, or, specialty if it differs 
from that of the defendant. An estate's expert, who was a vascular surgeon, presented significant 
evidence that the standard of care for the diagnosis of deep vein thrombosis (DVT) did not vary 
based on whether the patient presented herself to a family practitioner, an emergency room 
physician, or a specialist in vascular disease. Accordingly, the expert's lack of recent experience 
in emergency medicine did not render him unqualified to testify as to the standard of care 
required of an emergency room physician in a medical malpractice action brought by the estate 
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of the patient who died as a result of a pulmonary thromboembolism. The physician was asked to 
“rule out” DVT much as the surgeon had been asked to do in the surgeon's practice.105  
b. Elements and Requisites of Vascular Surgery Malpractice 
A breach of duty by the defendant and a causal connection between the defendant's 
breach of duty and the resulting harm to the plaintiff are essential elements of a cause of action in 
negligence. A defendant's negligence is "a cause" of a plaintiff's injury or damage if it was a 
substantial factor in producing the injury or damage. The element of proximate cause can be 
established through a chain of circumstances from which the ultimate fact required to be 
established is reasonably and naturally inferable.
106
  
The elements of damages in an action involving thrombophlebitis are the same as the 
elements of damages in personal injury actions generally. The disabling effects of 
thrombophlebitis hold major implications for future earning power. In workers' compensation 
and personal injury actions, it is essential to establish the physical dysfunctions that exist, and the 
degree to which they restrict the victim's movements, strength, and endurance. In personal injury 
actions, it is important to demonstrate how those permanent injuries translate into economic loss. 
Counsel should consider the value of expert testimony by a vocational expert on the issue of 
physical restrictions and the potential for rehabilitation, and by an economic expert on the 
financial impact of the disability and the adaptations it requires.
107
  
                                                        
105
 Schutte v. Mooney, 165 Ohio App. 3d 56, 844 N.E.2d 899 (2d Dist. Montgomery County 
2006).  
106
 Sheridan v. St. Luke's Regional Medical Center, 135 Idaho 775 (2001); Neade v. Portes, 193 
Ill. 2d 433 (2000); Merriam v. Wanger, 2000 ME 159, 757 A.2d 778 (Me. 2000); Francoeur v. 
Piper, 146 N.H. 525 (2001); Powell v. Margileth, 259 Va. 244 (2000); Paul v. Skemp, 2001 WI 
42 (2001). 
 
107
 Vermilya v Nationwide Mut. Ins. Co. 280 Pa Super 504, 421 A2d 835 (1980).  
33 
Future and past medical treatment are important items of damages in a personal injury 
action for thrombophlebitis. If the trial is held before all medical treatment is completed, the 
court should be presented with detailed evidence as to the need for such treatment, and of the 
best possible estimate of the cost of the future procedures. The cost of monitoring the plaintiff's 
condition for a reasonable period of time is a readily ascertainable element of such future 
damages. Early settlement of the plaintiff's claim can be risky in cases where there is a 
significant possibility of delayed onset of thrombophlebitis or its subsequent complications.
108
  
VI. The Missing Link: Causation 
In the vascular surgery malpractice action, an essential element which must be 
established by a preponderance of the trial evidence is proof of causation, or proximate cause. 
The trial evidence must show that plaintiff patient's physical injuries were actually or 
proximately caused by a malpractice act or omission in the defendant's rendition of a vascular 
diagnosis, or the performance of a vascular procedure or surgery. Actual cause in this context 
may be expressed as follows: But for the negligent conduct of the vascular surgeon in diagnosis 
or vascular surgical treatment, the physical injuries suffered by plaintiff patient would not have 
occurred.
109
  
In contrast, proximate cause is that in which the physician or heath care provider’s act or 
omission was a substantial factor in bringing about the loss or damage. Both proximate and 
actual cause is difficult to prove and is often where plaintiffs fail in proving their case. Breach of 
the standard of care can come in many forms: failure to promptly diagnose and treat patient; 
failure to take adequate patient history including current symptoms; failure to take adequate 
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history of patient risk factors (example: prior blood clotting problems, family history of clotting 
disorders, smoking, obesity, etc.); failure to conduct adequate physical examination; failure to 
order imaging diagnostics; failure to review or interpret imaging properly; failure to order other 
laboratory tests (example: blood test, etc.); failure to record data in medical record; failure to 
admit patient for emergency care, but none of this matters unless one can determine that this was 
at least a substantial factor in creating or causing the injury suffered. 
Establishing causation of thrombophlebitis can be complicated by the fact that the 
precipitating factors in the disease are intricately interrelated. Any one of these factors has the 
potential for constituting a cause different from the one being claimed by the plaintiff. Because 
of this, if it is supported by the facts, the defense should propound the theory that the major 
contributing cause of the plaintiff's condition was a cause unrelated to defendant's conduct. Also, 
a defendant physician may be able to show that the patient had a preexisting condition or was 
predisposed to thrombophlebitis.
110
 The defendant may concede that the condition complained of 
did not exist before the incident, while at the same time showing that the alleged condition 
developed from, or was caused by, a preexisting abnormality or proclivity, making the injury 
inevitable regardless of the alleged negligence.  
Preexisting condition can be an absolute defense if it is found that the defendant's 
conduct played no substantial role in the current manifestation or exacerbation of the disease. 
Predisposition can be effective in a similar way, if it is proven that the onset of the condition 
complained of was inevitable, thus negating the causal link that is the source of liability. For 
example, evidence of preexisting heart or kidney disease, cancer, or a predisposing condition 
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such as obesity or multiple pregnancies would tend to show that plaintiff's thrombophlebitis was 
not caused by defendant's conduct. In establishing preexisting condition, the defense should 
show that the plaintiff had symptoms of the condition prior to the incident complained of. An 
examination of the injured leg at the time of the injury is important in this regard, because the 
examination may reveal a preexisting abnormal condition of the blood vessels in the legs that 
would explain the otherwise unlikely development of such complications following the injury. 
Similarly, an examination at the time of injury, if negative for thrombophlebitis, may be an 
important means of refuting or minimizing the causal link between the injury and a related 
subsequent complication of thrombophlebitis. 
The case law regarding pulmonary embolisms and claims of malpractice demonstrate the 
struggle plaintiffs in the past have had with this issue. 
For example, although a university medical center breached the standard of care by 
failing to use anti-embolic stockings during the patient's breast reduction surgery, there was 
insufficient evidence that the non-use of the stockings was a proximate cause of the patient's 
death from a blood clot. In this case, no medical expert testified that it was more probable than 
not that the medical center's failure to use the stockings caused the patient's fatal pulmonary 
embolus, and while there was testimony that the anti-embolic stockings could help prevent 
formation of blood clots during surgery, there was no expert testimony that the stockings more 
likely than not would have prevented the patient's fatal pulmonary embolus.
111
  
In Lyon v. Bryan,
112
 the jury's finding that the physician's negligence did not cause the 
patient to suffer injuries was supported by adequate evidence. In this action, the patient alleged 
that the physician negligently failed to diagnose a postoperative blood clot condition that caused 
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the patient to suffer a pulmonary embolism. The court reasoned that the jury was free to 
disregard the expert witness's testimony on causation even though the expert's opinion was 
unchallenged. The jury verdict was not internally inconsistent based upon the finding that the 
physician was negligent but did not cause the patient's injuries. Thus, no new trial was 
warranted. Evidence was introduced that questioned the accuracy of the physician's notes, and 
since neither the jury instructions nor verdict form limited the jury's consideration of the 
physician's negligence, the jury could reasonably have concluded that the physician was 
negligent in failing to take and keep proper notes but that this failure in no way caused the 
patient's injuries. 
In a medical malpractice action, the plaintiff failed to show that the absence of a specific 
discharge instruction from the emergency-room physician to the patient concerning avoidance of 
deep vein thrombosis during recovery from a small fracture of the greater trochanter of the right 
leg was a proximate cause of the development of the blood clot that dislodged, traveled to the 
heart, and caused the patient's sudden death. In this case, the widower did not show that the 
injury more likely than not resulted from the physician's alleged negligence in failing to instruct 
the patient to try to be as mobile as possible.
113
  
Similarly, a patient who was prescribed a birth control patch failed to demonstrate that 
the patch manufacturer's alleged failure to warn a prescribing physician of the increased risk of 
blood clots associated with the use of hormonal contraceptives was a cause-in-fact and proximate 
cause of the patient's development of deep vein thrombosis (DVT) in a left calf vein. This was 
because no additional information regarding the patch would have changed the physician's 
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decision to continue the patient's use of the patch. In this case, the patient had been aware of the 
risks associated with use of the patch.
114
  
Another complication involving causation is the patient itself. If it is negligence on the 
part of physician not to give the proper discharge instructions to a patient to prevent a clot, it is 
equally negligent for the patient not to follow those instructions. For example, a plaintiff who 
brought an action for medical malpractice alleging that negligence on the part of a physician in 
treating her broken leg had caused her to suffer thrombophlebitis, unsuccessfully contended that 
the trial court had abused its discretion in allowing the physician to present a comparative 
negligence defense - a defense based on the plaintiff's failure to follow postoperative 
instructions—to the jury. The court held that the plaintiff's testimony on cross–examination, 
coupled with the testimony of the defense experts was substantial, competent evidence to support 
the jury's finding of comparative negligence, and the trial court properly refused to disturb the 
jury's verdict finding that the plaintiff was 45% comparatively negligent. Specifically, the court 
pointed to the plaintiff's admission, on cross-examination, that during recovery and contrary to 
the physician's advice, she had not maintained her legs in an elevated position above her heart, 
and she had not quit smoking. Additionally, the court observed, the plaintiff testified that during 
the last three or four days preceding the attack of thrombophlebitis, she had no activity, despite 
the physician’s instructions to do otherwise.115  
The issue of causation in the legal context stems from the ultimate fact that the causation 
and formation of thrombosis and pulmonary embolism is hidden and underdeveloped. Medical 
researchers do not know exactly how the development of venous thrombosis is affected by 
alterations in blood flow (including stasis), vessel wall damage with exposure of sub-endothelial 
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structures, and altered blood coagulability. But it is likely that each of these factors contributes to 
thrombosis, although the contribution of each factor might vary under differing circumstances.
116
 
In any event, interest in the cause of venous thrombosis is now moving away from these 
relatively simple concepts. More attention is being focused on the balance between activator and 
inhibitor substances secreted by vessel walls, and between levels of procoagulants and 
anticoagulants circulating in the bloodstream. Many of these compounds exist in a delicate 
balance in which inhibition and activation are evenly matched. Alteration of this balance may 
encourage thrombosis. The development of methods capable of measuring minute quantities of 
activators and inhibitors helps researchers determine the role of these compounds in the 
development of thrombosis.
117
 Until this research is completed and more is known about the 
formation of thrombosis, this element will be the hardest to prove in any plaintiff’s malpractice 
claim. Outside clear cases of negligence on behalf of a vascular surgeon or medical professional, 
causation will be the missing link necessary for any recovery despite this horrible and harmful 
disease.  
VII. Conclusion 
In conclusion, blood clots and deep vein thrombosis are very serious conditions that must 
be met with equally serious medical and legal efforts in order to prevent them from becoming 
fatal. The medical ramifications are clear, while the legal considerations are highly inconclusive. 
Whether it is litigation arising out of a vascular diagnosis or treatment, DVT and pulmonary 
embolism create a vast number of issues that must be solved in order to reduce the incidence of 
this condition. One of the hurdles we must tackle as a medical and legal community is the issue 
                                                        
116
 Ogston, Venous Thrombosis: Causation and Prediction 56 (1987).  
117
 Browse, Burnand & Thomas, Diseases of the Veins: Pathology, Diagnosis and Treatment 456 
(1988). 
39 
of causation and its relationship to pulmonary embolism and blood clots generally. The initiation 
of blood clots can arise from a host of different sources, and understanding the timing of the 
onset or initiation of thrombi is critical. Better diagnostic tools and a better understanding of this 
conditions will improve the ability of the scientific, medical and legal communities to determine 
the potential signs and symptoms that accompany this condition. These will also help determine 
what preventative measures both citizens and physicians can take to stop clots from reaching the 
lethal points in our bodies. Helping to understand the legal ramifications surrounding this 
condition can only better the understanding of how this condition can be prevented, and this 
forensic analysis of pulmonary embolism aims to do just that.  
 
